GamaMabs Pharma is a clinical-stage immuno-oncology company developing optimized therapeutic antibodies for the treatment of cancer.

quesque c'est viagra
achat cialis 20mg pas cher
a quelle moment prendre le viagra
ou acheter cialis en suisse
viagra pour homme chez la femme
prix du cialis 20mg en belgique
générique du viagra pfizer
avis site vente cialis

GamaMabs’ lead project is the monoclonal antibody (mAb) GM102 which targets Anti-Müllerian Human Receptor II (AMHRII), an unaddressed specific target in gynecological cancers.

The company develops low-fucose EMABling® antibodies with increased tumor cell killing properties through the activation of immune system cells.